Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

NCT00361296 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Myelodysplastic Syndromes

Interventions

BIOLOGICAL: K562/GM-CSF cell vaccine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]